Overview and Diagnostic Definition

The Pediatric Acute Lung Injury Consensus Conference-2 (PALICC-2, published 2023) updated the 2015 diagnostic and management criteria for Pediatric Acute Respiratory Distress Syndrome (PARDS). PALICC-2 harmonizes non-invasive respiratory modalities, establishes objective definitions for non-intubated children, and refines severity stratifications.

PALICC-2 Core Diagnostic Criteria

  1. Timing: Acute onset within 7 days of a known clinical insult (sepsis, severe pneumonia, aspiration, trauma, pancreatitis, transfusion).
  2. Origin of Edema: Respiratory failure not fully explained by left ventricular heart failure or fluid overload (confirmed clinically or via echocardiography).
  3. Radiographic Findings: New bilateral pulmonary infiltrates/opacities on chest radiography (CXR) or computed tomography (CT) consistent with acute pulmonary parenchymal disease.
    • Alternative in Resource-Limited Settings (RLS): Chest ultrasound showing bilateral B-lines or consolidation can be utilized if CXR/CT is unavailable.
  4. Oxygenation Defect: Stratified by mode of respiratory support (Invasive Mechanical Ventilation vs Non-Invasive Respiratory Support).

Severity Stratification

1. Invasively Ventilated PARDS

Assessed after a minimum stabilization period of 4 hours on mechanical ventilation, utilizing arterial blood gas measurements or pulse oximetry:

$$\text{Oxygenation Index (OI)} = \frac{\text{Mean Airway Pressure (MAP in cmH}_2\text{O)} \times \text{FiO}_2 \times 100}{\text{PaO}_2\text{ (in mmHg)}}$$$$\text{Oxygen Saturation Index (OSI)} = \frac{\text{Mean Airway Pressure (MAP in cmH}_2\text{O)} \times \text{FiO}_2 \times 100}{\text{SpO}_2\text{ (when }\text{SpO}_2 \le 97\%)}$$
Severity TierInvasive OI Criteria (Arterial ABG)Invasive OSI Criteria (Pulse Oximetry)
Mild PARDS$4 \le \text{OI} < 8$$5 \le \text{OSI} < 7.5$
Moderate PARDS$8 \le \text{OI} < 16$$7.5 \le \text{OSI} < 12.3$
Severe PARDS$\text{OI} \ge 16$$\text{OSI} \ge 12.3$

2. Non-Invasive PARDS (BiPAP / CPAP)

Applied in children on full-face mask or nasal mask CPAP or BiPAP with continuous positive airway pressure $\ge 5\text{ cmH}_2\text{O}$:

  • Criteria: $\text{PaO}_2 / \text{FiO}_2 \le 300\text{ mmHg}$ OR $\text{SpO}_2 / \text{FiO}_2 \le 264$ (with $\text{SpO}_2 \le 97\%$).

3. "Possible PARDS" (Novel PALICC-2 Category)

Identifies children on high-flow nasal oxygen before intubation to prompt early lung-protective care and monitoring:

  • Oxygen Modality: High-Flow Nasal Cannula (HFNC) at flow rates:
    • Age $<1\text{ year}$: Flow $\ge 1.5\text{ L/kg/min}$
    • Age $\ge 1\text{ year}$: Flow $\ge 2.0\text{ L/kg/min}$ (or total flow $>30\text{ L/min}$)
  • Oxygenation Threshold: $\text{SpO}_2 / \text{FiO}_2 \le 264$ (with $\text{SpO}_2 \le 97\%$).
  • Radiology: Bilateral infiltrates on imaging.
flowchart TD
    A["Acute Respiratory Deterioration (< 7 days) + Bilateral Infiltrates"] --> B{"Current Respiratory Support?"}
    
    B -->|"HFNC (≥ 1.5–2 L/kg/min)"| C{"SpO2 / FiO2 ≤ 264?"}
    C -->|Yes| D["Possible PARDS<br/>(Monitor ROX, avoid delayed intubation)"]
    C -->|No| E["Acute Hypoxemic Failure (Not PARDS)"]
    
    B -->|"CPAP / BiPAP (PEEP ≥ 5 cmH2O)"| F{"PaO2/FiO2 ≤ 300 OR SpO2/FiO2 ≤ 264?"}
    F -->|Yes| G["Non-Invasive PARDS"]
    
    B -->|"Invasive Mechanical Ventilation"| H["Calculate OI or OSI (post 4h)"]
    H -->|"OI 4–7.9 OR OSI 5–7.4"| I["Mild PARDS"]
    H -->|"OI 8–15.9 OR OSI 7.5–12.2"| J["Moderate PARDS"]
    H -->|"OI ≥ 16 OR OSI ≥ 12.3"| K["Severe PARDS"]

Lung-Protective Mechanical Ventilation Protocol

PALICC-2 mandates physiologic lung protection to prevent Ventilator-Induced Lung Injury (VILI):

Ventilatory ParameterTarget / GuidelineClinical Rationale & Evidence
Tidal Volume ($V_T$)$4–8\text{ mL/kg}$ (Predicted Body Weight)$3–6\text{ mL/kg}$ for severely non-compliant lungs; $6–8\text{ mL/kg}$ for preserved compliance. Avoids volutrauma.
Inspiratory Plateau Pressure ($P_{\text{plat}}$)$\le 28\text{ cmH}_2\text{O}$ (up to $30\text{ cmH}_2\text{O}$ if chest wall compliance is reduced)Prevents alveolar overdistension and barotrauma.
Driving Pressure ($\Delta P = P_{\text{plat}} - \text{PEEP}$)$< 15\text{ cmH}_2\text{O}$Strongest independent ventilator predictor of mortality in adult and pediatric ARDS cohorts.
PEEP TitrationTitrate according to pediatric high-PEEP / FiO2 titration matrices ($10–15\text{ cmH}_2\text{O}$ in severe disease)Maintains functional residual capacity (FRC) and prevents cyclic alveolar collapse (atelectotrauma).
Gas Exchange TargetsPermissive Hypercapnia: Target $\text{pH } 7.20–7.35$; $\text{PaCO}_2$ allowable up to $55–70\text{ mmHg}$Minimizes mandatory minute ventilation demands. Absolute contraindication: elevated intracranial pressure or severe pulmonary hypertension.
Oxygenation Goals$\text{SpO}_2\ 92–97\%$ if $\text{PEEP} < 10$; permissive hypoxemia $\text{SpO}_2\ 88–92\%$ if $\text{PEEP} \ge 10\text{ cmH}_2\text{O}$Avoids oxygen toxicity and free-radical pulmonary capillary endothelial damage.

Ancillary and Rescue Management

flowchart TD
    A["Invasive PARDS Confirmed"] --> B["Apply Lung-Protective Ventilation<br/>(Vt 4–8 mL/kg, Pplat ≤ 28, ΔP < 15, High PEEP)"]
    B --> C{"Severity Assessment"}
    
    C -->|"Mild (OI 4–8)"| D["Conservative Fluid Management<br/>Sedation titration"]
    C -->|"Moderate (OI 8–16)"| E["Prone Positioning (≥ 16 h/day)<br/>Early Neuromuscular Blockade (24–48 h)"]
    C -->|"Severe (OI ≥ 16)"| F["Prone Positioning + Deep Paralysis<br/>Trial Inhaled Nitric Oxide (iNO 10–20 ppm)"]
    
    F --> G{"Refractory Hypoxemia<br/>(OI > 40 or pH < 7.15 despite optimization)?"}
    G -->|Yes| H["HFOV Rescue Ventilation<br/>OR Veno-Venous (VV) ECMO Referral"]
    G -->|No| I["Continue Lung-Protective De-escalation"]

1. Prone Positioning

  • Indication: Moderate-to-severe PARDS ($\text{OI} \ge 8$ or $\text{OSI} \ge 7.5$).
  • Duration: Minimum continuous $\ge 16\text{ hours/day}$.
  • Mechanism: Improves dorsal alveolar recruitment, optimizes ventilation-perfusion ($V/Q$) matching, reduces transpulmonary pressure gradients, and facilitates dependent secretion drainage.
  • Evidence: PROSEVA trial (adults) demonstrated clear 28-day mortality benefit (16% vs 32%); pediatric prospective cohorts confirm sustained improvement in OI and extubation success.

2. Neuromuscular Blockade (NMB)

  • Agent: Cisatracurium or vecuronium infusion for 24 to 48 hours.
  • Indications: Severe PARDS, patient-ventilator dyssynchrony, elevated transpulmonary driving pressures, or refractory hypoxemia.
  • Caveat: Titrate with Train-of-Four (TOF) monitoring; avoid prolonged courses $>48\text{ hours}$ to prevent critical illness myopathy.

3. Inhaled Nitric Oxide (iNO)

  • Role: Selective pulmonary vasodilator (10–20 ppm).
  • PALICC-2 Position: Not routinely recommended for all PARDS cases. Reserved as rescue therapy for:
    • Documented pulmonary hypertension or acute cor pulmonale.
    • Refractory hypoxemia as a bridge to ECMO.
    • If no oxygenation response within 4 hours, iNO must be discontinued.

4. Fluid Stewardship

  • Conservative fluid strategy post-initial resuscitation (e.g., target cumulative net-zero or negative fluid balance by Day 3–5).
  • Fluid overload $>10–15\%$ body weight correlates directly with prolonged mechanical ventilation days, secondary PICU infections, and increased mortality.

5. Advanced Rescue: HFOV and ECMO

  • High-Frequency Oscillatory Ventilation (HFOV): Rescue mode for severe air leaks or refractory hypercapnic/hypoxemic failure where conventional protective targets fail.
  • Extracorporeal Membrane Oxygenation (ECMO):
    • Modality: Veno-Venous (VV) ECMO for isolated respiratory failure; Veno-Arterial (VA) ECMO if concomitant myocardial failure or septic cardiomyopathy.
    • Trigger Criteria: Refractory hypoxemic failure with $\text{OI} > 40$ or uncompensated hypercapnic acidosis ($\text{pH} < 7.15$) despite prone positioning and maximal protective ventilation.

Comparison: Berlin Definition vs PALICC-1 vs PALICC-2

FeatureBerlin Definition (2012, Adult)PALICC-1 (2015)PALICC-2 (2023)
Age ExclusionExcludes neonatesExcludes neonates with cyanotic CHD or RDSHarmonized across pediatrics (post-neonatal through 18 yr)
Non-Invasive Diagnostic RoleCPAP $\ge 5\text{ cmH}_2\text{O}$ (Mild ARDS only)CPAP / BiPAP with full maskCPAP / BiPAP + HFNC defined ("Possible PARDS")
Primary Metric$\text{PaO}_2 / \text{FiO}_2$ ratio onlyOI primary, OSI secondaryOI and OSI fully co-validated with specific cutoff tiers
High-Flow CannulaExcludedNot formally definedIncluded with specific flow thresholds ($\ge 1.5–2\text{ L/kg/min}$)
Prone PositioningRecommended in severe ARDSSuggestedStrongly recommended $\ge 16\text{ h/day}$ in moderate-severe
Driving PressureNot specified in criteriaAcknowledgedFormal target: $\Delta P < 15\text{ cmH}_2\text{O}$
Resource-Limited Settings (RLS)No criteriaClinical guidance onlyUltrasound-based criteria & pulse-oximetry formulas